The Marburg vaccine has only been tested in adults aged 18 and older, with no current plans to conduct trials in children.

Sabin Nsanzimana said most of the victims were healthcare workers in the intensive care unit.

Marburg, a highly infectious hemorrhagic fever, is closely related to the Ebola virus and is transmitted through direct contact with blood and bodily fluids.